1. Home
  2. INDV vs PAGP Comparison

INDV vs PAGP Comparison

Compare INDV & PAGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$32.54

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Logo Plains GP Holdings L.P. Units representing Limited Partner Interests

PAGP

Plains GP Holdings L.P. Units representing Limited Partner Interests

HOLD

Current Price

$23.32

Market Cap

4.7B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDV
PAGP
Founded
N/A
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Natural Gas Distribution
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.7B
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
INDV
PAGP
Price
$32.54
$23.32
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$22.11
AVG Volume (30 Days)
2.2M
1.7M
Earning Date
06-08-2026
05-08-2026
Dividend Yield
N/A
7.15%
EPS Growth
8100.00
370.00
EPS
1.64
0.27
Revenue
$1,239,000,000.00
$44,262,000,000.00
Revenue This Year
N/A
$12.42
Revenue Next Year
N/A
N/A
P/E Ratio
$20.09
$86.57
Revenue Growth
4.29
N/A
52 Week Low
$8.69
$16.69
52 Week High
$38.00
$24.76

Technical Indicators

Market Signals
Indicator
INDV
PAGP
Relative Strength Index (RSI) 55.14 46.12
Support Level $31.70 $22.87
Resistance Level $32.42 $24.00
Average True Range (ATR) 1.18 0.43
MACD 0.39 -0.17
Stochastic Oscillator 73.89 9.17

Price Performance

Historical Comparison
INDV
PAGP

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

About PAGP Plains GP Holdings L.P. Units representing Limited Partner Interests

Plains GP Holdings LP owns and operates midstream energy infrastructure and provides logistics services for crude oil, natural gas liquids (NGL), and natural gas. The group manages its operations through two operating segments: Crude Oil segment operations generally consist of gathering and transporting crude oil using pipelines (including gathering systems), trucks, and, at times, on barges or railcars; and NGL segment operations involve NGL storage and terminalling from NGL assets located in the Southwestern United States. It generates the majority of its revenue from the Crude Oil segment. Its geographic markets are the United States and Canada. It generates the majority of its revenue from the United States.

Share on Social Networks: